BigBear.ai heads into its August 4 earnings report with one of the tightest short positioning setups in the market — a combination of extreme short interest, near-zero borrow availability, and options skewed firmly toward calls.
The borrow market tells the sharpest part of the story. Availability has collapsed to just 1.8% of shares outstanding, meaning for every 55 shares already lent out, barely one remains available to new short sellers. That reading has been at or near zero for most of July — the 52-week low hit 0% on multiple sessions this month. Despite that constraint, short interest has continued to climb: 33.2% of the free float is currently sold short, up 4% over the past week and nearly 8% over the past month. The cost to borrow, at 1.87%, has actually eased sharply — down more than 60% from a month ago — suggesting short sellers who are already in have locked in positions rather than racing to add new ones. ORTEX's short score for BBAI has crept to 72.6, near the high end of its recent range, ranking in the bottom 4th percentile of the universe on this metric. With 33% short interest and borrow effectively gone, any upside surprise in Monday's print creates a mechanically difficult exit for a crowded short base.
Options traders, however, are not positioned for that squeeze. The put/call ratio has dropped to 0.31, nearly two standard deviations below its 20-day average — its lowest reading in a year — pointing to unusually heavy call positioning. That's a notable divergence: the lending market says short sellers are entrenched and trapped, while the options market says buyers are actively reaching for upside. The stock closed at $2.79, down 24% over the past month and down roughly 52% year-to-date, so the call-heavy positioning reflects a depressed base rather than unbridled optimism.
The fundamental debate is stark. Bulls point to the Ask Sage product targeting roughly $25 million in ARR, a cleaner balance sheet, and exposure to government AI spending that aligns with current policy priorities. Bears have the harder data: Q3 2025 revenue fell to $33.1 million from $41.5 million a year earlier, full-year guidance was cut by more than $35 million at the midpoint, and gross margins have been compressing. The most recent analyst action, Cantor Fitzgerald trimming its target from $5 to $4 while maintaining a Neutral rating as of July 31, frames the Street's view cleanly — limited downside conviction, but no enthusiasm either. The sole Buy-rated coverage at HC Wainwright carries a $6 target, implying more than 100% upside from current levels, though the firm has been cutting that target steadily from $9 a year ago. At a price-to-book above 27x for a company generating losses, valuation offers no floor.
The print will test whether BigBear.ai can show any revenue stabilisation credible enough to loosen the grip of a short base that has nowhere easy to go.
See the live data behind this article on ORTEX.
Open BBAI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
